title: Pathways towards an effective immunotherapy for Parkinson's disease.
abstract: Immunizations that target specific types of immune responses are used commonly to prevent microbial infections. However, a range of immune responses may prove necessary to combat the ravages of neurodegenerative diseases. The goal is to eliminate the 'root' cause of neurodegenerative disorders, misfolded aggregated proteins, while harnessing adaptive immune responses to promote neural repair. However, immunization strategies used to elicit humoral immune responses against aberrant brain proteins have yielded mixed success. While specific proteins can be cleared, the failures in halting disease progression revolve, in measure, around adaptive immune responses that promote autoreactive T cells and, as such, induce a meningoencephalitis, accelerating neurodegeneration. Thus, alternative approaches for protein clearance and neural repair are desired. To this end, our laboratories have sought to transform autoreactive adaptive immune responses into regulatory neuroprotective cells in Parkinson's disease. In this context, induction of immune responses against modified brain proteins serves to break immunological tolerance, while eliciting adaptive immunity to facilitate neuronal repair. How to harness the immune response in the setting of Parkinson's disease requires a thorough understanding of the role of immunity in human disease and the ways to modify such immune responses to elicit therapeutic gain. These are discussed in this review.
authors.affiliation: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, USA.
authors.forename: Jessica A L
authors.initials: JA
authors.lastname: Hutter-Saunders
authors.forename: Rodney Lee
authors.initials: RL
authors.lastname: Mosley
authors.forename: Howard E
authors.initials: HE
authors.lastname: Gendelman
mesh_terms: D056704:Adaptive Immunity / Q000187:drug effects; D018450:Disease Progression; D006801:Humans; D056724:Immunity, Humoral / Q000187:drug effects; D007167:Immunotherapy / Q000379:methods*; D019636:Neurodegenerative Diseases / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D010300:Parkinson Disease / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*
references.citation: J Exp Med. 1986 Aug 1;164(2):594-604
references.pmid: 3487617
references.citation: Nat Cell Biol. 2002 Feb;4(2):160-4
references.pmid: 11813001
references.citation: Acta Neuropathol. 1990;80(5):493-8
references.pmid: 2251906
references.citation: Science. 1983 Sep 9;221(4615):1082-4
references.pmid: 6308771
references.citation: Neurochem Res. 1988 Jul;13(7):679-84
references.pmid: 3412555
references.citation: J Neurosci. 2009 Oct 28;29(43):13435-44
references.pmid: 19864556
references.citation: Science. 1997 Jun 27;276(5321):2045-7
references.pmid: 9197268
references.citation: J Exp Med. 1990 Jan 1;171(1):141-57
references.pmid: 2136906
references.citation: Nature. 2000 Dec 21-28;408(6815):979-82
references.pmid: 11140685
references.citation: J Neurosci. 1996 Apr 15;16(8):2508-21
references.pmid: 8786427
references.citation: Brain Res Bull. 2009 Oct 28;80(4-5):224-32
references.pmid: 19631259
references.citation: Clin Microbiol Rev. 2004 Oct;17(4):942-64, table of contents
references.pmid: 15489356
references.citation: Eur J Immunol. 2008 Apr;38(4):921-4
references.pmid: 18395861
references.citation: Nature. 1991 Mar 21;350(6315):230-2
references.pmid: 2005978
references.citation: Neurology. 1992 Jan;42(1 Suppl 1):51-6; discussion 57-60
references.pmid: 1549202
references.citation: J Neural Transm Suppl. 2009;(73):311-5
references.pmid: 20411789
references.citation: Nature. 1999 Jul 8;400(6740):173-7
references.pmid: 10408445
references.citation: Novartis Found Symp. 2003;252:6-16; discussion 16-23, 106-14
references.pmid: 14609209
references.citation: Br J Exp Pathol. 1948 Feb;29(1):58-69
references.pmid: 18865105
references.citation: Neurology. 1998 Jun;50(6 Suppl 6):S18-22; discussion S44-8
references.pmid: 9633682
references.citation: Hum Vaccin. 2010 Nov;6(11):948-52
references.pmid: 20980801
references.citation: J Neurochem. 2010 Sep 1;114(5):1261-76
references.pmid: 20524958
references.citation: J Neuroimmunol. 2007 Feb;183(1-2):60-8
references.pmid: 17196666
references.citation: Lancet Neurol. 2009 Apr;8(4):382-97
references.pmid: 19296921
references.citation: Science. 2003 Oct 31;302(5646):841
references.pmid: 14593171
references.citation: Science. 2003 Feb 14;299(5609):1057-61
references.pmid: 12522256
references.citation: Int J Biochem Cell Biol. 2009 Oct;41(10):2015-24
references.pmid: 19460457
references.citation: Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9435-40
references.pmid: 15197276
references.citation: Nat Med. 2003 May;9(5):589-95
references.pmid: 12669033
references.citation: J Immunol. 2010 Mar 1;184(5):2261-71
references.pmid: 20118279
references.citation: Adv Neurol. 2001;86:83-9
references.pmid: 11554012
references.citation: Curr Alzheimer Res. 2005 Jul;2(3):355-65
references.pmid: 15974901
references.citation: J Neuropathol Exp Neurol. 2008 Dec;67(12):1149-58
references.pmid: 19018246
references.citation: Parkinsonism Relat Disord. 2005 Dec;11(8):493-8
references.pmid: 16154792
references.citation: Eur J Immunol. 2000 Jun;30(6):1538-43
references.pmid: 10898488
references.citation: Lancet Neurol. 2008 Jun;7(6):474-5
references.pmid: 18485311
references.citation: Brain Res Mol Brain Res. 2005 Mar 24;134(1):84-102
references.pmid: 15790533
references.citation: Arthritis Rheum. 2006 Mar;54(3):864-76
references.pmid: 16508968
references.citation: Immunology. 2010 Feb;129(2):154-69
references.pmid: 20561356
references.citation: Dev Biol. 1989 May;133(1):140-7
references.pmid: 2651179
references.citation: Brain Res. 1989 Jul 10;491(2):394-7
references.pmid: 2765895
references.citation: Neurology. 1995 Jan;45(1):51-5
references.pmid: 7824134
references.citation: Curr Opin Neurol. 2007 Jun;20(3):351-7
references.pmid: 17495632
references.citation: Annu Rev Neurosci. 1999;22:219-40
references.pmid: 10202538
references.citation: Neuron. 2005 Jun 16;46(6):857-68
references.pmid: 15953415
references.citation: Nat Med. 2004 Jul;10 Suppl:S18-25
references.pmid: 15298006
references.citation: J Neuroimmune Pharmacol. 2008 Jun;3(2):59-74
references.pmid: 18202920
references.citation: Nat Genet. 1998 Feb;18(2):106-8
references.pmid: 9462735
references.citation: Lancet. 2004 Sep 25-Oct 1;364(9440):1167-9
references.pmid: 15451224
references.citation: Nat Med. 2000 Aug;6(8):916-9
references.pmid: 10932230
references.citation: Ann Neurol. 2009 Nov;66(5):591-6
references.pmid: 19938101
references.citation: Mov Disord. 2011 May;26(6):1072-82
references.pmid: 21626552
references.citation: Acta Neurol Scand. 1994 Sep;90(3):160-6
references.pmid: 7847055
references.citation: Neurology. 2011 Mar 8;76(10):863-9
references.pmid: 21368281
references.citation: Curr Opin Investig Drugs. 2008 May;9(5):478-84
references.pmid: 18465657
references.citation: J Immunol. 2007 Feb 15;178(4):2018-27
references.pmid: 17277105
references.citation: Neurology. 2003 Jan 14;60(1):69-73
references.pmid: 12525720
references.citation: Proc Natl Acad Sci U S A. 1998 May 26;95(11):6469-73
references.pmid: 9600990
references.citation: Drugs Aging. 2003;20(2):101-13
references.pmid: 12534311
references.citation: J Neurochem. 2008 Mar;104(6):1504-25
references.pmid: 18036154
references.citation: Neurology. 1974 May;24(5):431-41
references.pmid: 4857104
references.citation: Diabetes. 2009 Mar;58(3):652-62
references.pmid: 19074986
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5473-8
references.pmid: 12702778
references.citation: Nature. 1997 Aug 28;388(6645):839-40
references.pmid: 9278044
references.citation: J Neuroimmunol. 2010 Aug 25;225(1-2):100-11
references.pmid: 20554028
references.citation: Nat Immunol. 2003 Apr;4(4):330-6
references.pmid: 12612578
references.citation: Drugs Aging. 2001;18(10):773-85
references.pmid: 11735624
references.citation: Science. 1996 Nov 15;274(5290):1197-9
references.pmid: 8895469
references.citation: Transplant Proc. 2008 Mar;40(2):459-61
references.pmid: 18374101
references.citation: Ann Neurol. 1999 Sep;46(3):419-24
references.pmid: 10482276
references.citation: Nature. 2000 Dec 21-28;408(6815):982-5
references.pmid: 11140686
references.citation: Cell Immunol. 2009;257(1-2):97-104
references.pmid: 19358983
references.citation: Immunol Rev. 2008 Jun;223:371-90
references.pmid: 18613848
references.citation: Annu Rev Immunol. 2002;20:197-216
references.pmid: 11861602
references.citation: J Neuropathol Exp Neurol. 1998 Apr;57(4):338-42
references.pmid: 9600227
references.citation: J Leukoc Biol. 2005 Dec;78(6):1327-38
references.pmid: 16204628
references.citation: Science. 2001 Jul 13;293(5528):263-9
references.pmid: 11431533
references.citation: J Immunol. 2009 Dec 1;183(11):7602-10
references.pmid: 19917691
references.citation: Mov Disord. 2008 Mar 15;23(4):474-83
references.pmid: 18044695
references.citation: Arch Neurol. 2001 Oct;58(10):1580-3
references.pmid: 11594915
references.citation: Mol Neurodegener. 2010 Mar 24;5:12
references.pmid: 20334662
references.citation: J Leukoc Biol. 2007 Nov;82(5):1083-94
references.pmid: 17675560
references.citation: Science. 2000 Nov 3;290(5493):985-9
references.pmid: 11062131
references.citation: Mult Scler. 2001 Aug;7(4):209-19
references.pmid: 11548979
references.citation: J Clin Invest. 2009 Jan;119(1):182-92
references.pmid: 19104149
references.citation: Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8850-5
references.pmid: 11438712
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10821-6
references.pmid: 9380718
references.citation: N Engl J Med. 2001 Nov 22;345(21):1515-21
references.pmid: 11794217
references.citation: Trends Pharmacol Sci. 2005 Jul;26(7):341-4
references.pmid: 15936832
references.citation: N Engl J Med. 2001 Mar 8;344(10):710-9
references.pmid: 11236774
references.citation: Acta Neuropathol. 1996;91(4):385-95
references.pmid: 8928615
references.citation: Ann Neurol. 2000 Oct;48(4):567-79
references.pmid: 11026440
references.citation: Neurobiol Dis. 2010 Mar;37(3):510-8
references.pmid: 19913097
references.citation: Neurotherapeutics. 2010 Oct;7(4):354-65
references.pmid: 20880500
references.citation: Ann Neurol. 2004 Feb;55(2):164-73
references.pmid: 14755719
references.citation: Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:1-13
references.pmid: 2700931
references.citation: Acta Neuropathol. 2010 Sep;120(3):277-86
references.pmid: 20644946
references.citation: Nature. 1996 Mar 21;380(6571):252-5
references.pmid: 8637574
references.citation: Arch Immunol Ther Exp (Warsz). 2009 May-Jun;57(3):199-204
references.pmid: 19479206
references.citation: Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11472-7
references.pmid: 11027347
references.citation: Acta Neuropathol. 2003 Sep;106(3):191-201
references.pmid: 12845452
references.citation: J Neurosurg. 2005 Feb;102(2):216-22
references.pmid: 15739547
references.citation: PLoS One. 2008 Jan 02;3(1):e1376
references.pmid: 18167537
references.citation: Neurochem Res. 2006 Jan;31(1):85-94
references.pmid: 16475001
references.citation: J Neuroimmune Pharmacol. 2012 Mar;7(1):60-73
references.pmid: 21932048
references.citation: J Immunol. 2004 Sep 15;173(6):3916-24
references.pmid: 15356140
references.citation: J Neurol. 2008 Mar;255 Suppl 1:3-11
references.pmid: 18317671
references.citation: Neuropathol Appl Neurobiol. 1995 Dec;21(6):505-17
references.pmid: 8745240
references.citation: Immunity. 2010 May 28;32(5):593-604
references.pmid: 20510870
references.citation: Prog Brain Res. 2010;184:237-64
references.pmid: 20887879
references.citation: MAbs. 2011 Jan-Feb;3(1):76-99
references.pmid: 21051951
references.citation: Eur J Neurol. 2011 Nov;18(11):1336-42
references.pmid: 21457177
references.citation: Nat Immunol. 2007 Feb;8(2):191-7
references.pmid: 17136045
references.citation: J Biol Chem. 1999 Apr 2;274(14):9843-6
references.pmid: 10092675
references.citation: Science. 1993 May 21;260(5111):1130-2
references.pmid: 8493557
references.citation: Am J Pathol. 1988 Jul;132(1):86-101
references.pmid: 2456021
references.citation: Lancet Neurol. 2002 May;1(1):3
references.pmid: 12849527
references.citation: Neurology. 1988 Aug;38(8):1285-91
references.pmid: 3399080
references.citation: Arch Neurol. 1989 Jun;46(6):615-31
references.pmid: 2786405
references.citation: Science. 2000 Oct 27;290(5492):767-73
references.pmid: 11052933
references.citation: Cell Transplant. 2007;16(3):285-99
references.pmid: 17503739
references.citation: J Exp Med. 2003 Jan 6;197(1):111-9
references.pmid: 12515818
references.citation: Acta Neuropathol. 2010 Jan;119(1):89-105
references.pmid: 20012873
references.citation: J Neurosci. 1990 Feb;10(2):558-70
references.pmid: 2406380
references.citation: Expert Rev Neurother. 2008 Jul;8(7):1125-39
references.pmid: 18590482
references.citation: Eur J Immunol. 1999 Sep;29(9):2705-14
references.pmid: 10508245
references.citation: J Leukoc Biol. 2004 Jul;76(1):15-24
references.pmid: 14966194
references.citation: Immunol Rev. 2005 Apr;204:184-94
references.pmid: 15790359
references.citation: Neuroscience. 1996 May;72(2):355-63
references.pmid: 8737406
references.citation: Adv Immunol. 2007;96:1-40
references.pmid: 17981203
references.citation: J Neuroimmunol. 2009 Nov 30;216(1-2):113-7
references.pmid: 19646767
references.citation: Arch Neurol. 1990 Nov;47(11):1210-6
references.pmid: 2122877
references.citation: Mol Neurodegener. 2010 Oct 28;5:43
references.pmid: 21029459
references.citation: Curr Opin Immunol. 2007 Oct;19(5):589-95
references.pmid: 17719760
references.citation: Nat Med. 2008 May;14(5):504-6
references.pmid: 18391962
references.citation: Curr Opin Immunol. 2009 Jun;21(3):274-80
references.pmid: 19524429
references.citation: Nature. 1995 Jan 26;373(6512):339-41
references.pmid: 7830767
references.citation: J Neurosci. 2008 Jul 23;28(30):7687-98
references.pmid: 18650345
references.citation: J Mol Neurosci. 2008;34(1):17-22
references.pmid: 18157654
references.citation: Nat Neurosci. 2005 Jun;8(6):752-8
references.pmid: 15895084
references.citation: J Neuroimmunol. 2002 Mar;124(1-2):83-92
references.pmid: 11958825
references.citation: Ann Neurol. 2003 Sep;54(3):403-14
references.pmid: 12953276
references.citation: Biochemistry. 2001 Sep 25;40(38):11604-13
references.pmid: 11560511
references.citation: J Alzheimers Dis. 2011;26(1):171-9
references.pmid: 21593566
references.citation: CNS Neurol Disord Drug Targets. 2010 Aug;9(4):471-81
references.pmid: 20522010
references.citation: Neurobiol Aging. 1988 Jul-Aug;9(4):339-49
references.pmid: 3263583
references.citation: Environ Health Perspect. 2003 Jun;111(8):1065-73
references.pmid: 12826478
references.citation: J Neurol. 2009 Aug;256 Suppl 3:270-9
references.pmid: 19711116
references.citation: Acta Neurol Scand. 2009 May;119(5):332-7
references.pmid: 18976327
references.citation: Neuroepidemiology. 2011;36(3):155-61
references.pmid: 21508649
references.citation: Neurosci Lett. 1995 Dec 29;202(1-2):17-20
references.pmid: 8787820
references.citation: J Immunol. 1995 Aug 1;155(3):1151-64
references.pmid: 7636184
references.citation: Acta Neuropathol. 2010 Jun;119(6):689-702
references.pmid: 20306269
references.citation: BioDrugs. 2001;15(6):351-5
references.pmid: 11520246
references.citation: Blood. 2009 Jan 22;113(4):827-36
references.pmid: 18941119
references.citation: J Immunol. 2008 Mar 15;180(6):3866-73
references.pmid: 18322194
references.citation: Lancet. 2009 Jun 13;373(9680):2055-66
references.pmid: 19524782
references.citation: Exp Mol Pathol. 2009 Oct;87(2):99-104
references.pmid: 19577564
references.citation: J Immunol. 2008 Jun 1;180(11):7112-6
references.pmid: 18490709
references.citation: Infect Immun. 2009 Apr;77(4):1465-74
references.pmid: 19168733
references.citation: Neurology. 2002 Sep 24;59(6):880-6
references.pmid: 12297571
references.citation: J Neuropathol Exp Neurol. 1999 Feb;58(2):138-52
references.pmid: 10029097
references.citation: Neurodegener Dis. 2008;5(3-4):194-6
references.pmid: 18322388
references.citation: J Neurosci. 2000 Aug 15;20(16):6309-16
references.pmid: 10934283
references.citation: Ann N Y Acad Sci. 2000 Apr;903:72-82
references.pmid: 10818491
references.citation: FASEB J. 2005 Apr;19(6):533-42
references.pmid: 15791003
references.citation: Annu Rev Immunol. 2004;22:531-62
references.pmid: 15032588
references.citation: J Neurol Sci. 1973 Dec;20(4):415-55
references.pmid: 4272516
references.citation: Drug Discov Today. 2005 Aug 15;10(16):1075-6
references.pmid: 16182188
references.citation: J Neuroimmunol. 2009 Oct 30;215(1-2):125-8
references.pmid: 19758707
references.citation: Semin Immunol. 1998 Oct;10(5):349-50
references.pmid: 9799708
references.citation: Science. 2005 May 27;308(5726):1314-8
references.pmid: 15831717
references.citation: Neurology. 1988 Nov;38(11):1682-7
references.pmid: 3185902
references.citation: Clin Immunol. 2008 Sep;128(3):294-305
references.pmid: 18534912
references.citation: J Neurochem. 2007 Oct;103(1):17-37
references.pmid: 17623039
references.citation: Blood. 2006 May 1;107(9):3632-8
references.pmid: 16397128
references.citation: Brain Res. 1992 Dec 18;599(1):83-97
references.pmid: 1362921
references.citation: Acta Neuropathol. 1988;76(6):550-7
references.pmid: 2974227
references.citation: Neuroscience. 2007 Jul 29;147(4):867-83
references.pmid: 17459594
references.citation: Acta Neurol Scand. 2007 Dec;116(6):374-9
references.pmid: 17986095
references.citation: Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15620-5
references.pmid: 12429857
references.citation: J Neurochem. 1998 Feb;70(2):699-707
references.pmid: 9453564
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2003 Aug;27(5):741-9
references.pmid: 12921904